Visus Therapeutics to Present at the Baird 2022 Global Healthcare Conference

SEATTLE--(BUSINESS WIRE)-- #conferences--Visus Therapeutics, Inc. (“Visus”), a clinical stage biopharmaceutical company focused on treating complex and multifactorial conditions from the front to the back of the eye, today announced that Ben Bergo, co-founder and chief executive officer, will present at the Baird 2022 Global Healthcare Conference on September 13th, 2022, at the InterContinental New York Barclay hotel. The presentation is scheduled for 12:50 PM Eastern Time on Tuesday, September 13th. Mr. Berg